Selective inhibitors of neuronal nitric oxide synthase (nNOS), which are devoid of any effect on the endothelial isoform (eNOS), may be required for the treatment of some neurological disorders. In our search for novel nNOS inhibitors, we recently described some 1-[(Aryloxy)ethyl]-1H-imidazoles as interesting molecules for their selectivity for nNOS against eNOS. This work reports a new series of 1-[(Aryloxy)alkyl]-1H-imidazoles in which a longer methylene chain is present between the imidazole and the phenol part of molecule. Some of these molecules were found to be more potent nNOS inhibitors than the parent ethylenic compounds, although this increase in potency resulted in a partial loss of selectivity. The most interesting compound was investigated to establish its mechanism of action and was found to interact with the tetrahydrobiopterin (BH4) binding site of nNOS, without interference with any other cofactors or substrate binding sites.
Get full access to this article
View all access options for this article.
References
1.
Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of the endothelium-derived factor. Nature327:524–526, 1987.
2.
Ignarro LJ, Buga GM, Wood GM, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA84:9265–9269, 1987.
3.
Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: The free radical nitric oxide. Ann Neurol32:297–311, 1992.
4.
Feldman PL, Griffith OW, Stuehr DJ. The surprising life of nitric oxide. Chem Eng News20:26–38, 1993.
Kerwin JF, Lancaster JR, Feldman PL. Nitric oxide: A new paradigm for second messengers. J Med Chem38:4343–4362, 1995.
8.
Macdonald JE. Nitric oxide synthase inhibitors. Annu Rep Med Chem31:221–230, 1996.
9.
Southan GJ, Szabò C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol51:383–394, 1996.
10.
Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des8:177–200, 2002.
11.
Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects. Br J Pharmacol110:219–224, 1993.
12.
Handy RLC, Wallace P, Gaffen ZA, Whitehead KJ, Moore PK. The antinociceptive effect of 1-(2-trifluoromethylphenyl)imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol116:2349–2350, 1995.
13.
Reif A, Frohlich LG, Kotsonis P, Frey A, Bommel HM, Wink DA, Pfleiderer W, Schmidt HHHW. Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem274:24921–24929, 1999.
14.
Huang H, Martasek P, Roman LJ, Masters BSS, Silverman RB. NW-Niroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem42:3147–3153, 1999.
15.
Wolff DJ, Datto GA, Samatovicz RA, Tempsick RA. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem268:9425–9429, 1993.
16.
Chabin RM, Mc Cauley E, Calaycay JR, Kelly TM, Mac Nau KL, Wolfe GC, Hutchinson NI, Madhusudanaraja S, Schmidt JA, Kozarich J W, Wong KK. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole. Biochemistry35:9567–9575, 1996.
17.
Salerno L, Sorrenti V, Guerrera F, Sarvà MC, Siracusa MA, Di Giacomo C, Vanella A. 1-[(Aryloxy)alkyl]-1H-imidazoles as inhibitors of neuronal nitric oxide synthase. Pharm Pharmacol Commun5:491–494, 1999.
18.
Salerno L, Sorrenti V, Guerrera F, Sarvà MC, Siracusa MA, Di Giacomo C. Vanella A. N-substituted-imidazoles as inhibitors of nitric oxide synthase: A preliminary screening. Pharmazie54:685–690, 1999.
19.
Sorrenti V, Di Giacomo C, Salerno L, Siracusa MA, Guerrera F, Vanella A. Inhibition of neuronal nitric oxide synthase by N-phenacyl imidazoles.Nitric oxide Biol Chem5:32–38, 2001.
Gorren AC, List BM, Schrammel A, Pitters E, Hemmens B, Werner ER, Schmidt K, Mayer B Tetrahydrobiopterin-free neuronal nitric oxide synthase: Evidence for two identical highly anticooperative pteridine binding sites. Biochemistry35:16735–16745, 1996.
22.
Berka V, Palmer G, Chen PF, Tsai AL. Effects of various imidazole ligands on heme conformation in endothelial nitric oxide synthase. Biochemistry37:6136–6144, 1998.
23.
Rodriguez-Crespo I, Gerber NC, Ortiz de Montellano PR. Endothelial nitric oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J Biol Chem271:11462–11467, 1996.
24.
Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem264:20496–20501, 1989.
25.
Tayeh MA, Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem264:19654–19658, 1989.
26.
Schmidt HHHW, Smith RM. Nakane M, Murad, F. Ca2+/Calmodulin-dependent NO synthase type I: A biopteroflavoprotein with Ca2+/Calmodulin-independent diaphorase and reductase activities. Biochemistry31:3243–3249, 1992.
27.
Reif DW, McCarthy DJ, Gregan E, Macdonald JE. Discovery and development of neuronal nitric oxide synthase inhibitors. Free Radical Biol Med28:1470–1477, 2000.
28.
Raman CS, Li H, Martàsek P, Kràl V, Masters BSS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center. Cell95:939–950, 1998.
29.
Werner ER, Pitters E, Schmidt K, Wachter H, Werner-Fellmayer G, Mayer B. Identification of the 4-amino analogue of tetrahydrobiopterin as a dithydropteridine reductase and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J320:193–196, 1996.
30.
Handy RLC, Moore PK. Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM). Life Sci60:389–394, 1997.
31.
McMillan K, Masters BSS. Prokaryotic expression of the heme-and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: Identification of the heme binding proximal thiolate ligand as cysteine-415 Biochemistry34:3686–3693, 1995.
32.
Frohlich LG, Kotsonis P, Traub H, Taghavi-Moghadam S, Al-Masoudi N, Hofman H, Strobel H, Matter H, Pfleiderer W, Schmidt HHHW. Inhibition of neuronal nitric oxide synthase by 4-amino pterine derivatives: Structure–activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor. J Med Chem42:4108–4121, 1999.
